BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33548970)

  • 41. Transjugular intrahepatic portosystemic shunt (TIPS) complications: what diagnostic radiologists should know.
    Mamone G; Milazzo M; Di Piazza A; Caruso S; Carollo V; Gentile G; Crinò F; Marrone G; Sparacia G; Maruzzelli L; Miraglia R
    Abdom Radiol (NY); 2022 Dec; 47(12):4254-4270. PubMed ID: 36123434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transjugular Portosystemic Stent Shunt: Impact of Right Atrial Pressure on Portal Venous Hemodynamics Within the First Week.
    Pitton MB; Weinmann A; Kloeckner R; Mittler J; Ruckes C; Düber C; Otto G
    Cardiovasc Intervent Radiol; 2022 Jan; 45(1):102-111. PubMed ID: 34853873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical application of the transjugular intrahepatic portosystemic stent-shunt in the emergency treatment of esophagogastric varices bleeding due to cirrhosis].
    You LY; Li YC; Yan D; Xu Y; Yang J; Yang LH; Cheng F; Yang JH
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):490-3. PubMed ID: 22152237
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.
    Qiu B; Zhao MF; Yue ZD; Zhao HW; Wang L; Fan ZH; He FL; Dai S; Yao JN; Liu FQ
    World J Gastroenterol; 2015 Nov; 21(43):12439-47. PubMed ID: 26604651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J; Li M; Zhang Y; Wang H; Huang M; Li Z; Chen J; Wu C; Qian J; Guan S; Jiang Z
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy.
    Rössle M; Piotraschke J
    Dig Dis; 1996; 14 Suppl 1():12-9. PubMed ID: 8872448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Machine Learning Insights: Predicting Hepatic Encephalopathy After TIPS Placement.
    İnce O; Önder H; Gençtürk M; Golzarian J; Young S
    Cardiovasc Intervent Radiol; 2023 Dec; 46(12):1715-1725. PubMed ID: 37978062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Kloster ML; Ren A; Shah KY; Alqadi MM; Bui JT; Lipnik AJ; Niemeyer MM; Ray CE; Gaba RC
    Dig Dis Sci; 2021 Nov; 66(11):4058-4062. PubMed ID: 33236314
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial).
    de Wit K; Schaapman JJ; Nevens F; Verbeek J; Coenen S; Cuperus FJC; Kramer M; Tjwa ETTL; Mostafavi N; Dijkgraaf MGW; van Delden OM; Beuers UHW; Coenraad MJ; Takkenberg RB
    BMJ Open Gastroenterol; 2020 Dec; 7(1):. PubMed ID: 33372103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt.
    Li Y; He X; Pang H
    Turk J Gastroenterol; 2019 Aug; 30(8):702-707. PubMed ID: 31418414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
    Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
    Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical study of transjugular intrahepatic portosystemic shunt with Viatorr stent in 43 cases].
    Zhou H; Yao X; Tang SH; Xie M; Feng ZS; Qin JP
    Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):54-59. PubMed ID: 33541024
    [No Abstract]   [Full Text] [Related]  

  • 54. Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients.
    Jabbour N; Zajko AB; Orons PD; Irish W; Bartoli F; Marsh WJ; Dodd GD; Aldreghitti L; Colangelo J; Rakela J; Fung JJ
    Liver Transpl Surg; 1996 Mar; 2(2):139-47. PubMed ID: 9346640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft.
    Luo X; Zhao M; Wang X; Jiang M; Yu J; Li X; Yang L
    PLoS One; 2019; 14(2):e0212658. PubMed ID: 30811467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pressure gradients, laboratory changes, and outcomes with transjugular intrahepatic portosystemic shunts in pediatric portal hypertension.
    Slowik V; Monroe EJ; Friedman SD; Hsu EK; Horslen S
    Pediatr Transplant; 2019 May; 23(3):e13387. PubMed ID: 30932316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conversion of failed transjugular intrahepatic portosystemic shunt to distal splenorenal shunt in patients with Child A or B cirrhosis.
    Selim N; Fendley MJ; Boyer TD; Galloway JR; Branum GD
    Ann Surg; 1998 Apr; 227(4):600-3. PubMed ID: 9563552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A comparison of efficacies between transjugular intrahepatic portosystemic shunt versus portoazygos devascularization in the treatment of portal hypertension with variceal bleeding].
    Xu XB; Chu JG; Huang H; Zhang HY; Zhang HY; Liu CL; Xiao M; Zhang H; Feng ZQ; Zhao G
    Zhonghua Yi Xue Za Zhi; 2012 Sep; 92(36):2542-5. PubMed ID: 23158794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [TIPS - Transjugular intrahepatic portosystemic shunt. A review].
    Carreiro G; da Luz Moreira A; Murad FF; Azevedo F; Coelho HS
    Arq Gastroenterol; 2001; 38(1):69-80. PubMed ID: 11586999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of mortality and overt hepatic encephalopathy undergoing transjugular intrahepatic portosystemic shunt: a retrospective cohort study.
    Li K; Cheng Y; Zhao R; Jiang H; Zhang L; Tong Y; Li S
    Abdom Radiol (NY); 2024 Mar; 49(3):908-918. PubMed ID: 37957372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.